Irreversible Electroporation of Human Primary Uveal Melanoma in Enucleated Eyes

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Mandel, Yossi ^a,b   Laufer, Shlomi ^b   Belkin, Michael ^c   Rubinsky, Boris ^d   Pe'er, Jacob ^e   Frenkel, Shahar ^e  

^a STANFORD UNIVERSITY   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ELECTRIC CONDUCTIVITY; ELECTRIC FIELD; ELECTRICAL EQUIPMENT; ELECTRODE; ELECTROPORATION; ELECTROPORATOR; ENUCLEATION; EX VIVO STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMPEDANCE; IRREVERSIBLE ELECTROPORATION; MEMBRANE DAMAGE; SCLERA; TUMOR ABLATION; UVEA MELANOMA;

ABLATION TECHNIQUES; AGED; AGED, 80 AND OVER; ELECTROPORATION; EYE; EYE ENUCLEATION; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; UVEAL NEOPLASMS;

EID: 84883522272     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071789     Document Type: Article

References (42)

1. Scotto J, Fraumeni JF Jr, Lee JA, (1976) Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 56: 489-491.
2. Frenkel S, Hendler K, Pe'er J, (2009) Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis. Isr Med Assoc J 11: 280-285.
3. Collaborative Ocular Melanoma Study Group (2006) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol 124: 1684-1693.
4. Collaborative Ocular Melanoma Study Group (2007) Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27. Ophthalmology 114: 1363-1371.
5. Puusaari I, Heikkonen J, Kivela T, (2004) Ocular complications after iodine brachytherapy for large uveal melanomas. Ophthalmology 111: 1768-1777.
6. Jones R, Gore E, Mieler W, Murray K, Gillin M, et al. (2002) Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects. Int J Radiat Oncol Biol Phys 52: 989-995.
7. Wen JC, Oliver SC, McCannel TA, (2009) Ocular complications following I-125 brachytherapy for choroidal melanoma. Eye (Lond) 23: 1254-1268.
8. Damato B, Lecuona K, (2004) Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology 111: 977-983.
9. Singh AD, Triozzi PL, (2008) Endoresection for choroidal melanoma: palliative or curative intent? Br J Ophthalmol 92: 1015-1016.
10. Karkhaneh R, Chams H, Amoli FA, Riazi-Esfahani M, Ahmadabadi MN, et al. (2007) Long-term surgical outcome of posterior choroidal melanoma treated by endoresection. Retina 27: 908-914.
11. Jensen OA, (1982) Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943-1952. Acta Ophthalmol (Copenh) 60: 161-182.
12. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, et al. (2005) Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol 123: 1639-1643.
13. Wolf H, Rols MP, Boldt E, Neumann E, Teissie J, (1994) Control by pulse parameters of electric field-mediated gene transfer in mammalian cells. Biophys J 66: 524-531.
14. Rols MP, Teissie J, (1998) Electropermeabilization of mammalian cells to macromolecules: control by pulse duration. Biophys J 75: 1415-1423.
15. Rols MP, Teissie J, (1998) Flow cytometry quantification of electropermeabilization. Methods Mol Biol 91: 141-147.
16. Rols MP, Delteil C, Golzio M, Teissie J, (1998) Control by ATP and ADP of voltage-induced mammalian-cell-membrane permeabilization, gene transfer and resulting expression. Eur J Biochem 254: 382-388.
17. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, et al. (1998) In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 16: 168-171.
18. Edd JF, Davalos RV, (2007) Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat 6: 275-286.
19. Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B, (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53: 1409-1415.
20. Miller L, Leor J, Rubinsky B, (2005) Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4: 699-705.
21. Rubinsky B, Onik G, Mikus P, (2007) Irreversible electroporation: a new ablation modality-clinical implications. Technol Cancer Res Treat 6: 37-48.
22. Mandel Y, Boris R, (2012) Treatment of Uveal Melanoma by Non-Thermal Irreversible Electroporation: Electrical and Bio-Heat Finite Element Model of the Human Eye. J Heat Transfer 134: 111101-111110.
23. Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, et al. (2007) Tumor ablation with irreversible electroporation. PLoS ONE 2: e1135.
24. Ivorra A, Rubinsky B, (2007) In vivo electrical impedance measurements during and after electroporation of rat liver. Bioelectrochemistry 70: 287-295.
25. Gehl J, Skovsgaard T, Mir LM, (2002) Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 1569: 51-58.
26. Bobanovic F, Bootman MD, Berridge MJ, Parkinson NA, Lipp P, (1999) Elementary [Ca2+]i signals generated by electroporation functionally mimic those evoked by hormonal stimulation. FASEB J 13: 365-376.
27. Hofmann F, Ohnimus H, Scheller C, Strupp W, Zimmermann U, et al. (1999) Electric Field Pulses Can Induce Apoptosis. Journal of Membrane Biology 169: 103-109.
28. Tracy CR, Kabbani W, Cadeddu JA, (2011) Irreversible electroporation (IRE): a novel method for renal tissue ablation. BJU Int 107: 1982-1987.
29. Beebe SJ, Fox PM, Rec LJ, Willis EL, Schoenbach KH, (2003) Nanosecond, high-intensity pulsed electric fields induce apoptosis in human cells. FASEB J 17: 1493-1495.
30. Vernier PT, Sun Y, Gundersen MA, (2006) Nanoelectropulse-driven membrane perturbation and small molecule permeabilization. BMC Cell Biol 7: 37.
31. Neumann E (1989) The relaxation hysteresis of membrane electroporation. In: E. Neumann AES, C Jordan, editor. Electroporation and electrofusion in Cell Biology. New York: Plenum. pp.61-82.
32. Logan PT, Fernandes BF, Di Cesare S, Marshall JC, Maloney SC, et al. (2008) Single-cell tumor dormancy model of uveal melanoma. Clin Exp Metastasis 25: 509-516.
33. Abbas A, Lichtman A (2003) Cellular and Molecular Immunology. 5th ed. Philadelphia: Saunders.
34. Mandel Y, Frenkel S, Laufer S, Rubinsky B, Belkin M, et al. (2011) Treatment Of Uveal Melanoma By Non-thermal Irreversible Electroporation- Mathematical Model, Animal And Preliminary Ex-vivo Human Experiments. Invest Ophthalmol Vis Sci 52: E-Abstract 3284.
35. Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, et al. (2010) Irreversible electroporation of the pancreas in swine: a pilot study. HPB (Oxford) 12: 348-351.
36. Rubinsky J, Onik G, Mikus P, Rubinsky B, (2008) Optimal parameters for the destruction of prostate cancer using irreversible electroporation. J Urol 180: 2668-2674.
37. Ivorra A, Al-Sakere B, Rubinsky B, Mir LM, (2009) In vivo electrical conductivity measurements during and after tumor electroporation: conductivity changes reflect the treatment outcome. Phys Med Biol 54: 5949-5963.
38. Ivorra A, Rubinsky B, (2006) Impedance analyzer for in vivo electroporation studies. Conf Proc IEEE Eng Med Biol Soc 1: 5056-5059.
39. Davalos RV, Mir IL, Rubinsky B, (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33: 223-231.
40. Davalos RV, Rubinsky B, Otten DM, (2002) A feasibility study for electrical impedance tomography as a means to monitor tissue electroporation for molecular medicine. IEEE Trans Biomed Eng 49: 400-403.
41. Folberg R, Arbieva Z, Moses J, Hayee A, Sandal T, et al. (2006) Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns. Am J Pathol 169: 1376-1389.
42. Laufer S, Ivorra A, Reuter VE, Rubinsky B, Solomon SB, (2010) Electrical impedance characterization of normal and cancerous human hepatic tissue. Physiol Meas 31: 995-1009.